Achyut Healthcare Ltd

Achyut Healthcare Ltd has filed a Statement of Deviation/Variation for the quarter ended June 30, 2026, confirming no deviations in the utilization of funds raised through a public issue and preferential issue. The company raised a total of Rs. 2,581.28 Lakhs across multiple tranches, with the latest allotment on March 23, 2026. The funds were primarily allocated for purchasing machinery and equipment, and for general corporate purposes. The filing, in accordance with SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, assures stakeholders that all raised capital has been used as disclosed.

Achyut Healthcare Limited announced the approval of its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors convened on August 13, 2026, to consider and approve these results, along with the accompanying Limited Review Report. The financial statements were prepared in compliance with Indian Accounting Standards and SEBI regulations. The company operates solely within the Pharmaceuticals Business segment. The results were reviewed by the Audit Committee and subsequently approved by the Board.

Achyut Healthcare Limited announced the outcome of its Board Meeting held on August 13, 2026. The Board of Directors considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2026, along with the Limited Review Report. The meeting commenced at 4:00 PM and concluded at 4:40 PM. The financial results were prepared in accordance with Indian Accounting Standards and comply with SEBI regulations. The company operates in a single reportable segment: Pharmaceuticals Business.

Achyut Healthcare Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting will take place at the company's registered office in Ahmedabad. Additionally, the trading window for dealing in the company's securities will remain closed until 48 hours after the declaration of these financial results, in compliance with SEBI regulations regarding insider trading.

Achyut Healthcare Limited announced that its Board of Directors has approved a Scheme of Amalgamation with Zenith Healthcare Limited. Achyut Healthcare will be amalgamated into Zenith Healthcare, leading to the dissolution of Achyut Healthcare without winding up. Zenith Healthcare will issue equity shares to Achyut Healthcare's shareholders as consideration. The scheme is subject to approvals from statutory authorities, including the National Company Law Tribunal (NCLT), and shareholders/creditors. The transaction is considered a related party transaction as promoters are from the same group, but it will not attract Section 188 of the Companies Act, 2013. The share exchange ratio has been determined by registered valuers.

Achyut Healthcare Limited's Board of Directors has approved a Scheme of Amalgamation with Zenith Healthcare Limited. The amalgamation, subject to regulatory and shareholder approvals, involves the dissolution of Achyut Healthcare without winding up and issuance of Zenith Healthcare shares to Achyut Healthcare's shareholders. The transaction is considered a related party transaction as promoters are from the same group, but will be conducted on an arm's length basis. Registered valuers have determined the share exchange ratio.

Achyut Healthcare Limited's Board of Directors has approved a Scheme of Amalgamation with Zenith Healthcare Limited. The amalgamation, subject to regulatory and shareholder approvals, involves the dissolution of Achyut Healthcare without winding up and issuance of equity shares by Zenith Healthcare as consideration. The transaction is considered a related party transaction as promoters are from the same group, but it will not attract Section 188 of the Companies Act, 2013. The Share Exchange Ratio has been determined by registered valuers.

Achyut Healthcare Limited announced that its Board of Directors has approved a Scheme of Amalgamation with Zenith Healthcare Limited. The amalgamation, which involves the dissolution of Achyut Healthcare without winding up and issuance of shares by Zenith Healthcare to Achyut's shareholders, is subject to regulatory and shareholder approvals. The transaction is considered a related party transaction as promoters are from the same group, but it will be discharged on an arm's length basis. Registered Valuers have determined the Share Exchange Ratio.

Achyut Healthcare Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI regulations and the company's internal code of conduct for designated persons. The trading window will remain shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The date for the board meeting to consider these results will be announced later.

Achyut Healthcare Ltd. has submitted a statement confirming no deviations or variations in the use of proceeds from its public issue for the half-year ended March 31, 2026, as per Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company raised funds through public and preferential issues, with allotment dates ranging from March 2022 to May 2026, totaling ₹360 Lakhs, ₹348 Lakhs, ₹520.80 Lakhs and ₹1572.48 Lakhs. Funds were allocated for purposes including machinery purchase, general corporate purposes, and preferential issues, with no deviations reported.